Moderna Covid vaccine shows ‘no specific safety concerns’: FDA

Washington - The FDA was upbeat on the vaccine.


Published: Tue 15 Dec 2020, 6:21 PM

Last updated: Tue 15 Dec 2020, 6:22 PM

The US Food and Drug Administration on Tuesday issued a positively-worded briefing document about the Moderna Covid-19 vaccine ahead of a meeting by experts on whether to grant it emergency approval.

Also read: US buys 200 million Moderna vax doses

The FDA was upbeat on the vaccine, saying there were “no specific safety concerns identified that would preclude issuance of an EUA (emergency use authorization” and confirmed an overall efficacy of 94.1 percent.

More news from